Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004678319 | SCV005179946 | uncertain significance | Inborn genetic diseases | 2024-05-09 | criteria provided, single submitter | clinical testing | The c.1146T>G (p.D382E) alteration is located in exon 11 (coding exon 10) of the WDR72 gene. This alteration results from a T to G substitution at nucleotide position 1146, causing the aspartic acid (D) at amino acid position 382 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005006483 | SCV005638207 | uncertain significance | Amelogenesis imperfecta hypomaturation type 2A3 | 2024-05-22 | criteria provided, single submitter | clinical testing |